{"schema_version":"secwatch.filing_event.v1","accession":"0001546380-25-000010","form_type":"8-K","ticker":"SMG","cik":"0000825542","company_name":"SCOTTS MIRACLE-GRO CO","filed_at":"2025-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.410342+00:00","generated_at":"2026-05-23T03:06:57.767809+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Scotts Miracle-Gro Q2 GAAP EPS $3.72; adjusted EBITDA $402.8M, reaffirms guidance","bullets":["Q2 GAAP EPS $3.72 vs $2.74 prior year; adjusted EPS $3.98 vs $3.69.","Total sales $1.42B down 7% YoY; U.S. Consumer sales down 5% to $1.31B.","GAAP gross margin 38.6% (up 820bps); adjusted gross margin 39.1% (up 380bps).","Adjusted EBITDA $402.8M vs $396.3M; net leverage improved to 4.41x from 6.95x.","Reaffirms full-year guidance for U.S. Consumer, but drops Hawthorne revenue guidance due to cannabis uncertainty."],"urls":{"canonical":"https://secwatch.observer/filing/0001546380-25-000010","json":"https://secwatch.observer/filing/0001546380-25-000010.json","markdown":"https://secwatch.observer/filing/0001546380-25-000010.md","text":"https://secwatch.observer/filing/0001546380-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/825542/000154638025000010/0001546380-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/825542/000154638025000010/smg-20250430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T03:06:57.767809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}